Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of Allopurinol

ClinicalTrials.gov ID: NCT01451645

Public ClinicalTrials.gov record NCT01451645. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if once-daily treatment with colchicine, compared to placebo, is effective in preventing gout flares in patients who are initiating therapy with allopurinol.

Study identification

NCT ID
NCT01451645
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Regeneron Pharmaceuticals
Industry
Enrollment
82 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2011 (Type not available)
Primary completion
Aug 2012 (Actual)
Completion
Sep 2012 (Actual)
Last update posted
May 12, 2014

2011 – 2012

United States locations

U.S. sites
37
U.S. states
25
U.S. cities
37
Facility City State ZIP Site status
Not listed Alabaster Alabama — —
Not listed Mesa Arizona — —
Not listed Upland California — —
Not listed Trumbull Connecticut — —
Not listed DeBary Florida — —
Not listed Jacksonville Florida — —
Not listed Kissimmee Florida — —
Not listed Canton Georgia — —
Not listed Boise Idaho — —
Not listed Lexington Kentucky — —
Not listed Bethesda Maryland — —
Not listed Reisterstown Maryland — —
Not listed Bingham Farms Michigan — —
Not listed Brooklyn Center Minnesota — —
Not listed Kansas City Missouri — —
Not listed Billings Montana — —
Not listed Elizabeth New Jersey — —
Not listed Albuquerque New Mexico — —
Not listed New York New York — —
Not listed Charlotte North Carolina — —
Not listed Hickory North Carolina — —
Not listed Morganton North Carolina — —
Not listed Winston-Salem North Carolina — —
Not listed Duncansville Pennsylvania — —
Not listed Reading Pennsylvania — —
Not listed West Reading Pennsylvania — —
Not listed Greer South Carolina — —
Not listed Mt. Pleasant South Carolina — —
Not listed Johnson City Tennessee — —
Not listed Dallas Texas — —
Not listed Katy Texas — —
Not listed San Antonio Texas — —
Not listed Salt Lake City Utah — —
Not listed West Jordan Utah — —
Not listed Norfolk Virginia — —
Not listed Seattle Washington — —
Not listed Wauwatosa Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01451645, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 12, 2014 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01451645 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →